Structure and function of the Hepatitis C Virus glycoproteins E1 and E2. [ 2007 - 2009 ]

Research Grant

Researchers: A/Pr Heidi Drummer (Principal investigator) ,  Dr Diah Elhassen ,  Dr Pantelis Poumbourios

Brief description Hepatitis C virus (HCV) infects approximately 3 % of the global human population with 150,000-200,000 HCV-infected individuals currently living in Australia. Chronic HCV infection is associated with recurrent, progressively worsening liver disease, liver cirrhosis and hepatocellular carcinoma. The current therapy (interferon-ribavirin) is effective in only 40 % of patients and is often associated with severe side-effects. The mechanisms that HCV uses to replicate in liver cells is poorly understood. In this project we aim to better understand how the viral glycoproteins, E1 and E2, function in the initiation of infection. In particular, we will examine how these glycoproteins bind to liver cell receptors and then mediate virus-cell membrane fusion. These processes lead to the penetration of the HCV genetic material into the cell where it is replicated. These studies are essential for the discovery of new targets for antiviral agents and vaccines.

Funding Amount $AUD 533,828.39

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant